Matinas BioPharma Holdings (MTNB) Return on Equity [ROE] (2014 - 2026)
Matinas BioPharma Holdings (MTNB) posted Return on Equity [ROE] of -276.57% for Q2 2026, down 38.01 percentage points from -238.55% a year earlier and down 99.54 percentage points from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Matinas BioPharma Holdings' Return on Equity [ROE] came in at -166.59%, up 14.15 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -116.56 percentage points (FY2020 to FY2025).
- In prior years, Matinas BioPharma Holdings' Return on Equity [ROE] was -180.73% in FY2024 (-98.63 pp), -82.11% in FY2023 (-26.93 pp), -55.18% in FY2022 (-12.61 pp) and -42.56% in FY2021 (+7.46 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2025.
- On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -35.65 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2026, with a gain of 120.74 percentage points; the weakest was Q1 2025, with a drop of 155.28 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -177.02% (Q1 2026), -123.29% (Q4 2025) and -195.67% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Matinas BioPharma Holdings | 16.34 Mn | 3.74 Mn | - | -276.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -276.57% |
| Mar 31, 2026 | -177.02% |
| Dec 31, 2025 | -123.29% |
| Sep 30, 2025 | -195.67% |
| Jun 30, 2025 | -238.55% |
| Mar 31, 2025 | -297.76% |
| Dec 31, 2024 | -210.46% |
| Sep 30, 2024 | -126.19% |
| Jun 30, 2024 | -141.18% |
| Mar 31, 2024 | -142.48% |
| Dec 31, 2023 | -112.11% |
| Sep 30, 2023 | -91.60% |
| Jun 30, 2023 | -75.02% |
| Mar 31, 2023 | -64.83% |
| Dec 31, 2022 | -65.35% |
| Sep 30, 2022 | -63.39% |
| Jun 30, 2022 | -60.18% |
| Mar 31, 2022 | -52.12% |
| Dec 31, 2021 | -44.67% |
| Sep 30, 2021 | -40.46% |
API Access
Matinas BioPharma Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();